| MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy J Halkein, SP Tabruyn, M Ricke-Hoch, A Haghikia, M Scherr, ... The Journal of clinical investigation 123 (5), 2143-2154, 2013 | 580 | 2013 |
| Placental growth factor, a member of the VEGF family, contributes to the development of choroidal neovascularization JM Rakic, V Lambert, L Devy, A Luttun, P Carmeliet, C Claes, L Nguyen, ... Investigative ophthalmology & visual science 44 (7), 3186-3193, 2003 | 418 | 2003 |
| Laser-induced choroidal neovascularization model to study age-related macular degeneration in mice V Lambert, J Lecomte, S Hansen, S Blacher, MLA Gonzalez, I Struman, ... Nature protocols 8 (11), 2197, 2013 | 404 | 2013 |
| MicroRNA-21 exhibits antiangiogenic function by targeting RhoB expression in endothelial cells C Sabatel, L Malvaux, N Bovy, C Deroanne, V Lambert, MLA Gonzalez, ... PloS one 6 (2), e16979, 2011 | 334 | 2011 |
| Further pharmacological and genetic evidence for the efficacy of PlGF inhibition in cancer and eye disease S Van de Veire, I Stalmans, F Heindryckx, H Oura, A Tijeras-Raballand, ... Cell 141 (1), 178-190, 2010 | 308 | 2010 |
| MMP‐2 and MMP‐9 synergize in promoting choroidal neovascularization V Lambert, B Wielockx, C Munaut, C Galopin, M Jost, T Itoh, Z Werb, ... The FASEB journal 17 (15), 2290-2292, 2003 | 234 | 2003 |
| Presence of oestrogen receptor type β in human retina C Munaut, V Lambert, A Noël, F Frankenne, M Deprez, JM Foidart, ... British journal of Ophthalmology 85 (7), 877-882, 2001 | 205 | 2001 |
| Role of plasminogen activator-plasmin system in tumor angiogenesis JM Rakic, C Maillard, M Jost, K Bajou, V Masson, L Devy, V Lambert, ... Cellular and Molecular Life Sciences CMLS 60 (3), 463-473, 2003 | 172 | 2003 |
| Matrix metalloproteinase-9 contributes to choroidal neovascularization V Lambert, C Munaut, M Jost, A Noël, Z Werb, JM Foidart, JM Rakic The American journal of pathology 161 (4), 1247-1253, 2002 | 137 | 2002 |
| Influence of plasminogen activator inhibitor type 1 on choroidal neovascularization V Lambert, C Munaut, A Noël, F Frankenne, K Bajou, R Gerard, ... The FASEB Journal 15 (6), 1021-1027, 2001 | 129 | 2001 |
| Matrix metalloproteinase-2 governs lymphatic vessel formation as an interstitial collagenase B Detry, C Erpicum, J Paupert, S Blacher, C Maillard, F Bruyère, ... Blood 119 (21), 5048-5056, 2012 | 112 | 2012 |
| ADAMTS-2 functions as anti-angiogenic and anti-tumoral molecule independently of its catalytic activity J Dubail, F Kesteloot, C Deroanne, P Motte, V Lambert, JM Rakic, ... Cellular and molecular life sciences 67 (24), 4213-4232, 2010 | 99 | 2010 |
| Anti-angiogenic therapy of exudative age-related macular degeneration: current progress and emerging concepts A Noël, M Jost, V Lambert, J Lecomte, JM Rakic Trends in molecular medicine 13 (8), 345-352, 2007 | 78 | 2007 |
| Sunitinib inhibits inflammatory corneal lymphangiogenesis B Detry, S Blacher, C Erpicum, J Paupert, L Maertens, C Maillard, ... Investigative ophthalmology & visual science 54 (5), 3082-3093, 2013 | 72 | 2013 |
| Correlation between P450 CYP1A1 inducibility, MspI genotype and lung cancer incidence M Jacquet, V Lambert, E Baudoux, M Muller, P Kremers, J Gielen European Journal of Cancer 32 (10), 1701-1706, 1996 | 68 | 1996 |
| Dose-dependent modulation of choroidal neovascularization by plasminogen activator inhibitor type I: implications for clinical trials V Lambert, C Munaut, P Carmeliet, RD Gerard, PJ Declerck, A Gils, ... Investigative ophthalmology & visual science 44 (6), 2791-2797, 2003 | 63 | 2003 |
| Mice without uPA, tPA, or plasminogen genes are resistant to experimental choroidal neovascularization JM Rakic, V Lambert, C Munaut, K Bajou, K Peyrollier, ... Investigative ophthalmology & visual science 44 (4), 1732-1739, 2003 | 63 | 2003 |
| Angiogenesis is not impaired in connective tissue growth factor (CTGF) knock-out mice EJ Kuiper, P Roestenberg, C Ehlken, V Lambert, ... Journal of Histochemistry & Cytochemistry 55 (11), 1139-1147, 2007 | 55 | 2007 |
| Dentin matrix protein 1 induces membrane expression of VE-cadherin on endothelial cells and inhibits VEGF-induced angiogenesis by blocking VEGFR-2 phosphorylation S Pirotte, V Lamour, V Lambert, ML Alvarez Gonzalez, S Ormenese, ... Blood, The Journal of the American Society of Hematology 117 (8), 2515-2526, 2011 | 41 | 2011 |
| Bone marrow-derived mesenchymal cells and MMP13 contribute to experimental choroidal neovascularization J Lecomte, K Louis, B Detry, S Blacher, V Lambert, S Bekaert, C Munaut, ... Cellular and Molecular Life Sciences 68 (4), 677-686, 2011 | 41 | 2011 |